DC Chemicals

All products / DC32550

BTdCPU
CAT. NO. DC32550

BTdCPU

Pack sizes and prices

Pack sizePrice
100 mg$650 USDRequest a quote / confirm availability →
250 mg$1,100 USDRequest a quote / confirm availability →
1g$2,200 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

BTdCPU is an activator of HRI. The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma. Combination therapy with rapamycin, an mTOR inhibitor, and BTdCPU, an activator of HRI, demonstrated additive effects on apoptosis in dex-resistant cells. Thus, specific activation of the eIF2α kinase HRI is a novel therapeutic target in MM that can augment current treatment strategies.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC32550
Product nameBTdCPU
CAS1257423-87-2
Molecular formulaC13H8Cl2N4OS
Molecular weight339.194
Purity>98%
SMILESO=C(Nc1ccc(Cl)c(Cl)c1)Nc1ccc2nnsc2c1

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — BTdCPU (DC32550)

Related research products

Browse newly added products